Melissa Seymour MBA Biogen

Melissa Seymour is the Chief Quality Officer for Biogen Inc. In her current role Melissa leads the PO&T organization in setting the quality strategy, implementation of quality processes and systems, and development of talent to ensure the highest level of quality in the pharmaceutical industry. Prior to this, Melissa served as VP of Global Quality Control assuming responsibility for the strategy and implementation of Global QC testing worldwide. Additionally, she spent several years as the VP of Corporate Quality with responsibility for global compliance and quality systems including management of Quality Systems, Internal and External Auditing and Global Affiliate GMP oversight. Melissa holds BS degrees in both Biological Sciences and Biochemistry from NC State University and an executive MBA from Duke University. She has over 25 years of experience in the quality arena including quality positions at Novo Nordisk pharmaceuticals and Glaxo Smith Kline. Melissa has been involved in the influencing of regulatory guidance through her participation on non-profit Boards of the PDA as well as Rx-360. She has been an advocate for simplification of PAC processes, participating in industry forums, writing articles and interacting with regulators. Melissa is an ASQ Certified Quality Engineer, Certified Quality Auditor and Certified Quality